Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2025

Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Numerator:

Net loss	$	(173,443)	$	(160,304)	$	(593,267)	$	(659,579)
Denominator:
Weighted average common shares outstanding—basic and diluted	105,815,038		94,372,159		103,391,267		87,936,923
Net loss per share — basic and diluted	$	(1.64)	$	(1.70)	$	(5.74)	$	(7.50)

Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:


	As of September 30,
	2025	2024
Options to purchase common shares	15,799,622	13,094,018
Warrants to purchase common shares	294,195	294,195
Restricted share units	1,414,446	279,657
Total	17,508,263	13,667,870

Biohaven Ltd. 10-Q